TriSalus Life Sciences, Inc. TLSI Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by TriSalus Life Sciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: TriSalus Life Sciences, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about TriSalus Life Sciences, Inc.'s operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TriSalus Life Sciences, Inc.'s operating cash flow?
- TriSalus Life Sciences, Inc. (TLSI) reported operating cash flow of -$6.48M in Q1 2026.
- How has TriSalus Life Sciences, Inc.'s operating cash flow changed year-over-year?
- TriSalus Life Sciences, Inc.'s operating cash flow decreased by 44.0% year-over-year, from -$4.5M to -$6.48M.
- What is the long-term trend for TriSalus Life Sciences, Inc.'s operating cash flow?
- Over 4 years (2021 to 2025), TriSalus Life Sciences, Inc.'s operating cash flow has grown at a 79.4% compound annual growth rate (CAGR), from -$1.74M to -$18.01M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.